Cardiotoxicity of Breast Cancer Chemotherapy. Review uri icon

Overview

abstract

  • Breast cancer is one of the leading causes of malignancy affecting women in the United States. Although many effective treatments are available, most come with notable side effects that providers and patients must take into consideration. Various classes of chemotherapeutic agents, including anthracyclines and human epidermal growth factor receptor-2 antagonists, are known to be toxic to myocardial tissue. In this review article, we discuss what is reported in the literature regarding the cardiotoxicity of these agents as well as how to monitor and prevent cardiac injury and dysfunction.

publication date

  • February 3, 2025

Research

keywords

  • Antineoplastic Agents
  • Breast Neoplasms
  • Cardiotoxicity
  • Heart Diseases

Identity

Scopus Document Identifier

  • 85217568103

Digital Object Identifier (DOI)

  • 10.1097/CRD.0000000000000589

PubMed ID

  • 37665235

Additional Document Info

volume

  • 33

issue

  • 2